{"id":5702,"date":"2020-03-09T15:39:39","date_gmt":"2020-03-09T14:39:39","guid":{"rendered":"http:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1.pdf"},"modified":"2020-03-09T15:39:39","modified_gmt":"2020-03-09T14:39:39","slug":"4-novobind-series-a-pr-20200218","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/seventure-partners-invests-in-novobind-the-vancouver-headquartered-animal-health-biologics-business\/4-novobind-series-a-pr-20200218\/","title":{"rendered":"4 – NovoBind Series A PR 20200218"},"author":3,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"acf":[],"yoast_head":"\n4 - NovoBind Series A PR 20200218 | Seventure<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1.pdf\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1.pdf\",\"url\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1.pdf\",\"name\":\"4 - NovoBind Series A PR 20200218 | Seventure\",\"isPartOf\":{\"@id\":\"https:\/\/www.seventure.fr\/#website\"},\"datePublished\":\"2020-03-09T14:39:39+00:00\",\"dateModified\":\"2020-03-09T14:39:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1.pdf#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1.pdf\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1.pdf#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.seventure.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Seventure Partners invests in Novobind, the Vancouver-headquartered animal health biologics business\",\"item\":\"https:\/\/www.seventure.fr\/en\/seventure-partners-invests-in-novobind-the-vancouver-headquartered-animal-health-biologics-business\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"4 – NovoBind Series A PR 20200218\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.seventure.fr\/#website\",\"url\":\"https:\/\/www.seventure.fr\/\",\"name\":\"Seventure\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.seventure.fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"4 - NovoBind Series A PR 20200218 | Seventure","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1.pdf","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1.pdf","url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1.pdf","name":"4 - NovoBind Series A PR 20200218 | Seventure","isPartOf":{"@id":"https:\/\/www.seventure.fr\/#website"},"datePublished":"2020-03-09T14:39:39+00:00","dateModified":"2020-03-09T14:39:39+00:00","breadcrumb":{"@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1.pdf#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1.pdf"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1.pdf#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.seventure.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Seventure Partners invests in Novobind, the Vancouver-headquartered animal health biologics business","item":"https:\/\/www.seventure.fr\/en\/seventure-partners-invests-in-novobind-the-vancouver-headquartered-animal-health-biologics-business\/"},{"@type":"ListItem","position":3,"name":"4 – NovoBind Series A PR 20200218"}]},{"@type":"WebSite","@id":"https:\/\/www.seventure.fr\/#website","url":"https:\/\/www.seventure.fr\/","name":"Seventure","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.seventure.fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1.pdf'><img loading=\"lazy\" decoding=\"async\" width=\"232\" height=\"300\" src=\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1-pdf-232x300.jpg\" class=\"attachment-medium size-medium\" alt=\"\" \/><\/a><\/p>\n"},"caption":{"rendered":""},"alt_text":"","media_type":"file","mime_type":"application\/pdf","media_details":{"sizes":{"thumbnail":{"file":"4-NovoBind-Series-A-PR-20200218-1-pdf-116x150.jpg","width":116,"height":150,"mime_type":"image\/jpeg","source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1-pdf-116x150.jpg"},"medium":{"file":"4-NovoBind-Series-A-PR-20200218-1-pdf-232x300.jpg","width":232,"height":300,"mime_type":"image\/jpeg","source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1-pdf-232x300.jpg"},"large":{"file":"4-NovoBind-Series-A-PR-20200218-1-pdf-791x1024.jpg","width":791,"height":1024,"mime_type":"image\/jpeg","source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1-pdf-791x1024.jpg"},"full":{"file":"4-NovoBind-Series-A-PR-20200218-1-pdf.jpg","width":1088,"height":1408,"mime_type":"application\/pdf","source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1-pdf.jpg"}}},"post":5700,"source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/03\/4-NovoBind-Series-A-PR-20200218-1.pdf","_links":{"self":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/media\/5702"}],"collection":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/comments?post=5702"}]}}